Cardiff Oncology, Inc.(CRDF)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRDF Cardiff Oncology, Inc.

休市中 12-12 16:00:00 EST

2.39

-0.08

-3.43%

盘后2.34

-0.05-2.09%

18:13 EST

最高2.50	最低2.37	成交量75.37万
今开2.49	昨收2.48	日振幅5.45%
总市值1.61亿	流通市值1.57亿	总股本6,736万
成交额182.89万	换手率1.15%	流通股本6,573万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRDF","market":"US","secType":"STK","nameCN":"Cardiff Oncology, Inc.","latestPrice":2.39,"timestamp":1765573200000,"preClose":2.475,"halted":0,"volume":753655,"hourTrading":{"tag":"盘后","latestPrice":2.34,"preClose":2.39,"latestTime":"18:13 EST","volume":16409,"amount":38960.03,"timestamp":1765581219685},"delay":0,"floatShares":65730400,"shares":67360564,"eps":-0.793959,"marketStatus":"休市中","change":-0.085,"latestTime":"12-12 16:00:00 EST","open":2.49,"high":2.5,"low":2.365,"amount":1828881.3995375,"amplitude":0.054545,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.793959,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"listingDate":1059624000000,"exchange":"NASDAQ","adjPreClose":2.475,"preHourTrading":{"tag":"盘前","latestPrice":2.5438,"preClose":2.475,"latestTime":"08:41 EST","volume":1230,"amount":3025.447851,"timestamp":1765546893870},"postHourTrading":{"tag":"盘后","latestPrice":2.34,"preClose":2.39,"latestTime":"18:13 EST","volume":16409,"amount":38960.03,"timestamp":1765581219685},"volumeRatio":0.5836037860957154,"impliedVol":0.2461,"impliedVolPercentile":0.056},"requestUrl":"/m/hq/s/CRDF/wiki","defaultTab":"wiki","newsList":[{"id":"1159387466","title":"Cardiff Oncology公布在ASH 2025中与Onvansertib联合进行的慢性骨髓单核细胞白血病的临床试验数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1159387466","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159387466?lang=zh_cn&edition=full","pubTime":"2025-12-09 05:06","pubTimestamp":1765227976,"startTime":"0","endTime":"0","summary":"Cardiff Oncology公布在ASH 2025中与Onvansertib联合进行的慢性骨髓单核细胞白血病的临床试验数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2588701535","title":"Cardiff Oncology, Inc.盘中异动 早盘大幅跳水5.04%报2.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588701535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588701535?lang=zh_cn&edition=full","pubTime":"2025-12-01 23:24","pubTimestamp":1764602671,"startTime":"0","endTime":"0","summary":"北京时间2025年12月01日23时24分，Cardiff Oncology, Inc.股票出现波动，股价大幅下挫5.04%。截至发稿，该股报2.17美元/股，成交量7.0432万股，换手率0.10%，振幅3.95%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为1.32%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201232432a71d34ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201232432a71d34ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2557305545","title":"Cardiff Oncology, Inc.盘中异动 股价大跌5.06%报2.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557305545","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557305545?lang=zh_cn&edition=full","pubTime":"2025-08-06 23:07","pubTimestamp":1754492869,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日23时07分，Cardiff Oncology, Inc.股票出现波动，股价大幅下跌5.06%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080623075094d3a1ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080623075094d3a1ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2556338027","title":"Cardiff Oncology, Inc.盘中异动 早盘急速跳水5.30%报2.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556338027","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556338027?lang=zh_cn&edition=full","pubTime":"2025-08-04 22:52","pubTimestamp":1754319165,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日22时52分，Cardiff Oncology, Inc.股票出现异动，股价快速跳水5.30%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Psyence Biomedical Ltd.、凯信远达涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为5198.02%、1334.85%、519.20%，振幅较大的相关个股有凯信远达、Psyence Biomedical Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为92.95%、77.54%、46.43%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508042252459733173e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508042252459733173e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2556826586","title":"Cardiff Oncology, Inc.2025财年第二财季实现净利润-13.94百万美元，同比减少18.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556826586","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556826586?lang=zh_cn&edition=full","pubTime":"2025-08-03 00:01","pubTimestamp":1754150490,"startTime":"0","endTime":"0","summary":"8月3日，Cardiff Oncology, Inc.公布财报，公告显示公司2025财年第二财季净利润为-13.94百万美元，同比减少18.34%；其中营业收入为121000.00美元，同比减少25.77%，每股基本收益为-0.21美元。从资产负债表来看，Cardiff Oncology, Inc.总负债17.13百万美元，其中短期债务721000.00美元，资产负债比为4.43，流动比率为4.43。机构评级：截至2025年8月3日，当前有6家机构对Cardiff Oncology, Inc.目标价做出预测，其中目标均价为11.75美元，其中最低目标价为3.50美元，最高目标价为19.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250803000235a47176e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250803000235a47176e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF"],"gpt_icon":0},{"id":"2555834804","title":"Cardiff Oncology, Inc.盘中异动 早盘急速跳水5.02%报2.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555834804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555834804?lang=zh_cn&edition=full","pubTime":"2025-07-31 22:35","pubTimestamp":1753972512,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日22时35分，Cardiff Oncology, Inc.股票出现异动，股价快速下跌5.02%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为2.67%。其相关个股中，Soligenix, Inc.、Silexion Therapeutics Corp、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Onconetix, Inc.、Soligenix, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为4478.00%、4406.27%、4370.19%，振幅较大的相关个股有Silexion Therapeutics Corp、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Soligenix, Inc.，振幅分别为97.88%、97.44%、90.40%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073122351394c682e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073122351394c682e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2555034707","title":"Cardiff Oncology, Inc.盘中异动 股价大跌5.04%报3.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555034707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555034707?lang=zh_cn&edition=full","pubTime":"2025-07-29 00:12","pubTimestamp":1753719135,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日00时12分，Cardiff Oncology, Inc.股票出现波动，股价大幅下挫5.04%。截至发稿，该股报3.77美元/股，成交量114.163万股，换手率1.72%，振幅8.26%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072900121594bfa975&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072900121594bfa975&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2551126026","title":"Cardiff Oncology, Inc.盘中异动 大幅上涨5.01%报4.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551126026","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551126026?lang=zh_cn&edition=full","pubTime":"2025-07-16 22:35","pubTimestamp":1752676541,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日22时35分，Cardiff Oncology, Inc.股票出现异动，股价快速上涨5.01%。截至发稿，该股报4.33美元/股，成交量40.496万股，换手率0.61%，振幅4.00%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.19%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716223541a44efb32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716223541a44efb32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2550131656","title":"Cardiff Oncology, Inc.盘中异动 早盘快速拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550131656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550131656?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:46","pubTimestamp":1752072397,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时46分，Cardiff Oncology, Inc.股票出现异动，股价大幅拉升5.08%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.42%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709224637979fc739&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709224637979fc739&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2549523637","title":"Cardiff Oncology, Inc.盘中异动 早盘急速拉升5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549523637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549523637?lang=zh_cn&edition=full","pubTime":"2025-07-08 21:32","pubTimestamp":1751981527,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日21时32分，Cardiff Oncology, Inc.股票出现异动，股价快速上涨5.21%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Prokidney Corp.、Plus Therapeutics, Inc.、Vor Biopharma Inc.涨幅较大，Zyversa Therapeutics, Inc.、Plus Therapeutics, Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为808.17%、124.01%、111.60%，振幅较大的相关个股有Prokidney Corp.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Rallybio Corporation，振幅分别为21.42%、17.98%、17.48%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708213208a69d4c97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708213208a69d4c97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2548540885","title":"Cardiff Oncology, Inc.盘中异动 快速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548540885","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548540885?lang=zh_cn&edition=full","pubTime":"2025-07-02 00:02","pubTimestamp":1751385751,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日00时02分，Cardiff Oncology, Inc.股票出现波动，股价大幅上涨5.08%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.21%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702000232a728c707&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702000232a728c707&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2545177258","title":"Cardiff Oncology, Inc.盘中异动 股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545177258","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545177258?lang=zh_cn&edition=full","pubTime":"2025-06-21 03:31","pubTimestamp":1750447870,"startTime":"0","endTime":"0","summary":"北京时间2025年06月21日03时31分，Cardiff Oncology, Inc.股票出现异动，股价快速上涨5.13%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.61%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，满足最大的医疗需求。消息层面，截至03时31分，《H.C. Wainwright维持Cardiff Oncology买入评级，维持目标价18美元》资讯为影响Cardiff Oncology, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621033110a4b52dad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621033110a4b52dad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2544908198","title":"Cardiff Oncology, Inc.盘中异动 急速跳水9.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544908198","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544908198?lang=zh_cn&edition=full","pubTime":"2025-06-18 21:31","pubTimestamp":1750253467,"startTime":"0","endTime":"0","summary":"北京时间2025年06月18日21时31分，Cardiff Oncology, Inc.股票出现异动，股价快速下跌9.19%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Aptevo Therapeutics Inc.、Biodexa Pharmaceuticals Plc、Geovax Labs, Inc.涨幅较大，Aptevo Therapeutics Inc.、Biodexa Pharmaceuticals Plc、Nucana Plc较为活跃，换手率分别为2402.68%、637.53%、116.39%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Biomx Inc.、Rallybio Corporation，振幅分别为21.45%、17.92%、11.18%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618213107a71095b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618213107a71095b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2518847203","title":"Cardiff Oncology, Inc.盘中异动 下午盘快速下挫5.19%报3.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518847203","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518847203?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:11","pubTimestamp":1741626690,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时11分，Cardiff Oncology, Inc.股票出现波动，股价快速跳水5.19%。截至发稿，该股报3.66美元/股，成交量38.3547万股，换手率0.58%，振幅5.19%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311011130a26a766f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311011130a26a766f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2517452649","title":"Cardiff Oncology, Inc.2024财年实现净利润-45.43百万美元，同比减少9.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517452649","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517452649?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363258,"startTime":"0","endTime":"0","summary":"3月8日，Cardiff Oncology, Inc.公布财报，公告显示公司2024财年净利润为-45.43百万美元，同比减少9.63%；其中营业收入为683000.00美元，同比增加39.96%，每股基本收益为-0.95美元。从资产负债表来看，Cardiff Oncology, Inc.总负债14.24百万美元，其中短期债务710000.00美元，资产负债比为6.83，流动比率为7.08。机构评级：截至2025年3月8日，当前有4家机构对Cardiff Oncology, Inc.目标价做出预测，其中目标均价为14.25美元，其中最低目标价为10.00美元，最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000249a2647fc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000249a2647fc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF"],"gpt_icon":0},{"id":"2517161846","title":"Cardiff Oncology, Inc.盘中异动 早盘大幅下挫5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517161846","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517161846?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:35","pubTimestamp":1741271739,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时35分，Cardiff Oncology, Inc.股票出现异动，股价急速下挫5.15%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223539963c4db0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223539963c4db0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2517946697","title":"Cardiff Oncology, Inc.盘中异动 急速上涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517946697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517946697?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:32","pubTimestamp":1741188766,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时32分，Cardiff Oncology, Inc.股票出现异动，股价急速拉升5.09%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.20%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305233246abe9c451&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305233246abe9c451&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRDF"],"gpt_icon":0},{"id":"2516559796","title":"Cardiff Oncology, Inc.盘中异动 快速下挫5.07%报4.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516559796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516559796?lang=zh_cn&edition=full","pubTime":"2025-03-04 00:12","pubTimestamp":1741018338,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日00时12分，Cardiff Oncology, Inc.股票出现波动，股价大幅跳水5.07%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为3454.38%、151.02%、139.72%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Radiopharm Theranostics Limited，振幅分别为206.20%、70.53%、53.50%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304001219abe65461&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304001219abe65461&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"2514320288","title":"Cardiff Oncology, Inc.盘中异动 大幅上涨5.30%报4.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514320288?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:35","pubTimestamp":1740753340,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时35分，Cardiff Oncology, Inc.股票出现异动，股价急速上涨5.30%。截至发稿，该股报4.28美元/股，成交量15.4379万股，换手率0.23%，振幅3.75%。Cardiff Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Cardiff Oncology, Inc.公司简介：Cardiff Oncology Inc是一家临床阶段的生物技术公司，利用PLK1抑制开发针对一系列癌症的新疗法，以满足最大的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223540abe0ebfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223540abe0ebfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRDF","BK4139"],"gpt_icon":0},{"id":"1118930078","title":"Cardiff Oncology第四季度GAAP每股收益$(0.21)优于预期$(0.24)，销售额$151.00K优于预期$94.17K","url":"https://stock-news.laohu8.com/highlight/detail?id=1118930078","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118930078?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:38","pubTimestamp":1740692305,"startTime":"0","endTime":"0","summary":"Cardiff Oncology报告季度每股亏损$，优于分析师一致预期的$，增长了12.5%。与去年同期的销售额$156.00千相比下降了3.21%。以上内容来自Benzinga Earnings专栏，原文如下：Cardiff Oncology  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 12.5 percent. This is unchanged from the same period last year.  The company reported quarterly sales of $151.00 thousand which beat the analyst consensus estimate of $94.17 thousand by 60.35 percent.  This is a 3.21 percent decrease over sales of $156.00 thousand the same period last","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Cardiff Oncology第四季度GAAP每股收益$(0.21)优于预期$(0.24)，销售额$151.00K优于预期$94.17K","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRDF"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cardiffoncology.com","stockEarnings":[{"period":"1week","weight":0.1327},{"period":"1month","weight":0.067},{"period":"3month","weight":0.1659},{"period":"6month","weight":-0.3727},{"period":"1year","weight":-0.2691},{"period":"ytd","weight":-0.4493}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cardiff Oncology, Inc.于2002年4月26日在佛罗里达州注册成立。该公司是一家临床阶段的生物技术公司，利用PLK1抑制（一种经过充分验证的肿瘤药物靶点）开发跨越一系列未满足医疗需求的癌症的新疗法。该公司的目标是通过onvansertib、公司口服和高选择性PLK1抑制剂以及标准护理疗法的治疗组合来针对肿瘤脆弱性。","yearOnYearQuotes":[{"month":1,"riseRate":0.461538,"avgChangeRate":0.003183},{"month":2,"riseRate":0.461538,"avgChangeRate":0.297462},{"month":3,"riseRate":0.384615,"avgChangeRate":0.093514},{"month":4,"riseRate":0.307692,"avgChangeRate":-0.07213},{"month":5,"riseRate":0.461538,"avgChangeRate":0.052242},{"month":6,"riseRate":0.384615,"avgChangeRate":0.287657},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.07931},{"month":8,"riseRate":0.571429,"avgChangeRate":0.100833},{"month":9,"riseRate":0.285714,"avgChangeRate":0.016213},{"month":10,"riseRate":0.5,"avgChangeRate":-0.014863},{"month":11,"riseRate":0.357143,"avgChangeRate":0.032453},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.024567}],"exchange":"NASDAQ","name":"Cardiff Oncology, Inc.","nameEN":"Cardiff Oncology, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cardiff Oncology, Inc.(CRDF)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cardiff Oncology, Inc.(CRDF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cardiff Oncology, Inc.,CRDF,Cardiff Oncology, Inc.股票,Cardiff Oncology, Inc.股票老虎,Cardiff Oncology, Inc.股票老虎国际,Cardiff Oncology, Inc.行情,Cardiff Oncology, Inc.股票行情,Cardiff Oncology, Inc.股价,Cardiff Oncology, Inc.股市,Cardiff Oncology, Inc.股票价格,Cardiff Oncology, Inc.股票交易,Cardiff Oncology, Inc.股票购买,Cardiff Oncology, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cardiff Oncology, Inc.(CRDF)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cardiff Oncology, Inc.(CRDF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}